EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.5 mg OF CHLORMADINONE ACETATE ON THE PLASMA LEVELS OF PROGESTERONE AND ON THE URINARY EXCRETION OF LUTEINIZING HORMONE AND TOTAL OESTROGENS

1970 ◽  
Vol 63 (4) ◽  
pp. 705-716 ◽  
Author(s):  
U. Larsson-Cohn ◽  
E. D. B. Johansson ◽  
L. Wide ◽  
C. Gemzell
Keyword(s):  
Luteinizing Hormone ◽  
Plasma Level ◽  
Urinary Excretion ◽  
Corpus Luteum ◽  
Plasma Levels ◽  
Chlormadinone Acetate ◽  
The Mean ◽  
Low Levels ◽  
The Difference ◽  
All Treatment

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of luteinizing hormone (LH) and total oestrogens were performed in 6 subjects during one control cycle, immediately followed by three cycles of daily treatment with 0.5 mg of chlormadinone acetate continuously. The control cycles were ovulatory according to the parameters investigated. Two of the women showed a normal LH excretion pattern in all treatment cycles. The four other subjects also had periodical variations in the LH excretion but no distinct midcycle peaks occurred. The mean oestrogen excretion was increased in all three treatment cycles but the difference was satistically significant only in the last two cycles. Compared with the treatment cycles, the sum of progesterone values was significantly decreased in the first two cycles. Chlormadinone acetate in this dose had no thermogenic effect. Three of the subjects showed bleeding irregularities which had no clear connection with the hormone variations measured in the study. It is suggested that the low levels of progesterone might be due to a defective corpus luteum function.

EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.3 mg OF NOREHTINDRONE ON THE PLASMA LEVELS OF PROGESTERONE AND ON THE URINARY EXCRETION OF PREGNANEDIOL AND TOTAL OESTROGENS

1970 ◽  
Vol 64 (1) ◽  
pp. 38-46 ◽  
Author(s):  
U. Larsson-Cohn ◽  
E. D. B. Johansson ◽  
C. Gemzell
Keyword(s):  
Plasma Level ◽  
Urinary Excretion ◽  
Corpus Luteum ◽  
Plasma Levels ◽  
Continuous Treatment ◽  
Daily Administration ◽  
Hormone Levels ◽  
Chlormadinone Acetate

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of total oestrogens and pregnanediol were performed in 7 subjects during one control cycle, followed by three months of daily continuous treatment with 0.3 mg of norethindrone (NET). The control cycles were ovulatory according to the parameters investigated. During treatment there was a tendency to cyclically increased oestrogen excretion, this being most marked in cycles with very depressed progesterone-pregnanediol levels. All the subjects showed signs of cyclical luteal activity. In most cases, the levels of progesterone and pregnanediol were lower than during the corresponding control cycles. It is suggested that this might be due to deficient corpus luteum function. The drug had no thermogenic effect. The length of the treatment cycles varied between 22 and 49 days. Only two of the women showed intermenstrual bleeding. It seems that 0.3 mg of NET has a weaker effect on the hormone levels than 0.5 mg of NET, but a stronger effect than 0.5 mg of chlormadinone acetate.

EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.03 mg OF d-NORGESTREL ON THE PLASMA LEVELS OF PROGESTERONE AND THE URINARY EXCRETION OF OESTROGENS

1971 ◽  
Vol 66 (4) ◽  
pp. 702-710 ◽  
Author(s):  
U. Larsson-Cohn ◽  
E. D. B. Johansson ◽  
C. Gemzell
Keyword(s):  
Body Temperature ◽  
Plasma Level ◽  
Urinary Excretion ◽  
Corpus Luteum ◽  
Basal Body ◽  
Plasma Levels ◽  
Daily Administration ◽  
Basal Body Temperature ◽  
Chlormadinone Acetate

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of oestrogens were performed in five subjects during one control cycle followed by three months of treatment with 0.03 mg of d-norgestrel. The control cycles were ovulatory according to the parameters investigated, although one of the women showed a monophasic basal body temperature. During treatment there was a tendency to a decrease of the oestrogen excretion. Three of the women showed one or several cycles with low progesterone levels. It is believed that this was due to a defective function of the corpus luteum. It seems that the effect of the present drug on the corpus luteum activity was about equal to that of chlormadinone acetate 0.5 mg daily, while 0.3 and 0.5 mg of norethindrone depressed the function more markedly.

EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.1 mg OF NORETHINDRONE ON THE PLASMA LEVELS OF PROGESTERONE AND ON THE URINARY EXCRETION OF LUTEINIZING HORMONE AND TOTAL OESTROGENS

1972 ◽  
Vol 71 (3) ◽  
pp. 551-556 ◽  
Author(s):  
Ulf Larsson-Cohn ◽  
Elof D. B. Johansson ◽  
Leif Wide ◽  
Carl Gemzell
Keyword(s):  
Luteinizing Hormone ◽  
Plasma Level ◽  
Urinary Excretion ◽  
Plasma Levels ◽  
Normal Pregnancy ◽  
Follicular Phase ◽  
Daily Treatment ◽  
Plasma Progesterone ◽  
Normal Ranges ◽  
The Mean

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of LH and oestrogens were performed in four women during one control cycle followed by three months of daily treatment with 0.1 mg of norethindrone. According to the plasma progesterone pattern, all four women seemed to ovulate during their control cycle. Two women became pregnant during their second cycle of treatment. During treatment all four women showed an atypical LH pattern without any distinct midcycle peak. The mean LH excretion during treatment was not significantly different from the mean level of follicular phase of normal cycles. The oestrogens and progesterone levels were within normal ranges. It is concluded that during treatment with 0.1 mg of norethindrone daily an apparently normal pregnancy may occur in spite of a different LH excretion pattern.

LUTEINIZING HORMONE (LH) AND PROGESTERONE IN PLASMA AND LH AND OESTROGENS IN URINE DURING 42 NORMAL MENSTRUAL CYCLES

1971 ◽  
Vol 68 (3) ◽  
pp. 502-512 ◽  
Author(s):  
Elof D. B. Johansson ◽  
Leif Wide ◽  
Carl Gemzell
Keyword(s):  
Luteinizing Hormone ◽  
Urinary Excretion ◽  
Plasma Levels ◽  
Luteal Phase ◽  
Maximum Level ◽  
Plasma Progesterone ◽  
Menstrual Cycles ◽  
Normal Menstrual Cycle ◽  
The Mean ◽  
Second Peak

ABSTRACT The plasma levels of luteinizing hormone (LH) and progesterone and the urinary excretion of LH and oestrogens were measured during the normal menstrual cycle of 22 young and healthy women. A total of 42 cycles were investigated. The urinary excretion of total oestrogens increased during several days before the rise of LH in the urine. The day of maximum excretion of LH and total oestrogens coincided during the midcycle period. The mid-cyclic rise in LH was found to occur on the same day in the plasma and urine and the days of maximum values coincided in 11 out of 16 cycles. In 5 cycles the maximum level was reached one day later in the urine. The plasma levels of progesterone started to increase during the LH and oestrogen peaks. The days for maximum levels of progesterone coincided with the second peak of urinary oestrogens. The levels of progesterone in the plasma reached values above 10 ng per ml in all normal cycles. The plasma levels of progesterone were below 1 ng per ml plasma when menstrual bleeding started. The length of the luteal phase was 14.4 ± 1.1 (s) days. The sum of daily urinary excretion of total oestrogens and the sum of the daily plasma progesterone levels varied within 15 per cent of the mean in five out of six women studied during more than two cycles. The variation in values for the sums of daily oestrogen excretion and plasma progesterone levels was considerably larger between menstrual cycles of different women than between menstrual cycles of the same woman.

EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.5 MG OF NORETHINDRONE ON THE PLASMA LEVELS OF PROGESTERONE AND ON THE URINARY EXCRETION OF LUTEINIZING HORMONE, PREGNANEDIOL AND TOTAL OESTROGENS

1970 ◽  
Vol 63 (2) ◽  
pp. 216-224 ◽  
Author(s):  
U. Larsson-Cohn ◽  
E. D. B. Johansson ◽  
L. Wide ◽  
C. Gemzell
Keyword(s):  
Luteinizing Hormone ◽  
Plasma Level ◽  
Urinary Excretion ◽  
Plasma Levels ◽  
The Other ◽  
Daily Treatment ◽  
Daily Administration ◽  
Menstrual Bleeding ◽  
Biphasic Pattern

ABSTRACT Daily determinations of the plasma level of progesterone and the urinary excretion of LH, total oestrogens and pregnanediol were performed in 4 subjects during one control cycle, immediately followed for 2 or 3 months of daily treatment with 0.5 mg of norethindrone continuously. The control cycles were ovulatory according to all the parameters investigated. During treatment the mid-cycle LH peak disappeared in all cases while the basal LH excretion showed considerable day to day variations. The excretion of total oestrogens was increased in all subjects but did not show the normal biphasic pattern. Periods of increased oestrogen excretion also appeared in the subjects with consistently low progesterone and pregnanediol levels during the treatment. In two cases, all signs of luteal activity immediately disappeared after the commencement of treatment. The other cases had one and three periods of increased progesterone and pregnanediol levels respectively. However, these periods were shorter than those of the control cycles. One of the subjects had regular menstrual bleeding while the other three had more or less irregular vaginal flows, often appearing during elevated but declining oestrogen excretion.

EFFECTS OF SYNTHETIC LH/FSH-RELEASING HORMONE (LRH) ON PLASMA LH AND FSH IN AMENORRHOEIC WOMEN

1974 ◽  
Vol 75 (4) ◽  
pp. 647-652 ◽  
Author(s):  
G. Rannevik ◽  
J. Thorell
Keyword(s):  
Urinary Excretion ◽  
Initial Response ◽  
Releasing Hormone ◽  
The Mean ◽  
The Difference ◽  
Serial Measurements

ABSTRACT Eight amenorrhoeic women were given 100 μg synthetic LRH (Hoechst) iv and im, respectively, at an interval of 2 weeks. Four of the women received the iv injection first and four the im injection. The urinary excretion of oestrogens and pregnanediol was low and unaltered throughout the test weeks. The effects of LRH were compared by serial measurements of the plasma LH and FSH during 8 h. The initial response of LH for up to 25 min and that of FSH for up to 60 min were equal whether LRH was given iv or im. The difference appeared later. Four hours after the injection the mean increase of LH to iv injection was 0.5 ng/ml (N. S.), while that to im injection was 1.9 ng/ml (P < 0.01). The corresponding values for FSH were 1.3 (P < 0.05) and 3.2 (P < 0.001). The effect of LRH administration im was thus found to be larger and more prolonged.

Pharmacodynamics of [D-Ser (t-Bu), Des-Gly]GnRH ethylamide (Buserelin®) in 6 normal volunteers.

1987 ◽  
Vol 115 (2) ◽  
pp. 235-242 ◽  
Author(s):  
Y. Reznik ◽  
B. P. Winiger ◽  
M. L. Aubert ◽  
P. C. Sizonenko
Keyword(s):  
Urinary Excretion ◽  
Precocious Puberty ◽  
Plasma Levels ◽  
Intranasal Administration ◽  
Cross Reaction ◽  
Disappearance Rate ◽  
Gnrh Analog ◽  
Male Adolescents ◽  
Normal Volunteers ◽  
The Mean

Abstract. The disappearance rate of [D-Ser(t-bu)6,des-Gly10]GnRH ethylamide (Buserelin®, HOE 766) was studied in plasma and urine after intranasal (300 μg) or sc (10 μg/kg) administration. A radioimmunoassay for HOE 766 was developed using 125I[D-Trp6,Des-Gly10]GnRH ethylamide as tracer and an antiserum raised against HOE 766. Cross-reaction with native GnRH was only 1.7%. Sensitivity was 1 pg/tube. In 6 male adolescents, the mean plasma HOE 766 concentration (± sem) was 0.46 ± 0.08, 0.50 ± 0.10, 0.28 ± 0.04, 0.24 ± 0.04, 0.13 ± 0.03, and 0.08 ± 0.02 μg/l 30, 60, 90, 120 and 180 min after the intranasal administration, respectively. Concomitant urinary excretion of HOE 766-like material was 9.43 ± 1.96 μg/4 h. There was a good correlation between integrated plasma levels and urinary excretion (r = 0.92). In the same 6 volunteers, the plasma HOE 766 levels were 21.2 ± 3.0, 25.9 ± 0.8, 21.2 ± 0.9, 17.1 ± 0.7, 12.8 ± 1.1, 8.9 ± 0.4, and 5.9 ± 0.8 μg/l 20, 40, 60, 90, 120, 180 and 240 min after sc injection, respectively. The mean urinary excretion was 543 ± 61 μg/4 h. In two girls with precocious puberty treated during 12 to 15 months with intranasal administration of HOE 766, urinary excretion of HOE 766-like material was shown to correlate well with the degree of inhibition of plasma 17β-E2and of plasma LH and FSH responses to a GnRH challenge. Thus, monitoring of HOE 766 in urine appears to be helpful for evaluating of intranasal therapy with a GnRH analog in precocious puberty.

Pattern of plasma progesterone, oestradiol-17β, luteinizing hormone and androgen in non-pregnant buffalo (Bubalus bubalis)

1982 ◽  
Vol 100 (2) ◽  
pp. 279-284 ◽  
Author(s):  
R. C. Arora ◽  
R. S. Pandey
Keyword(s):  
Luteinizing Hormone ◽  
Peak Level ◽  
Systemic Circulation ◽  
Bubalus Bubalis ◽  
High Concentration ◽  
Plasma Progesterone ◽  
Blood Samples ◽  
Androgen Level ◽  
The Mean ◽  
Low Levels

Abstract. Domestic buffaloes were used to characterize the pattern of progesterone, oestradiol-17β, LH and androgen in the systemic circulation following infertile insemination. Concentrations of hormones were measured by RIA in blood samples collected daily or at alternate days following insemination. The concentration of progesterone was lowest on the day of insemination, and increased significantly to a peak level of 4.00 ± 0.60 ng/ml by day 13 post insemination. After day 17, it declined significantly (P < 0.01) to reach low levels by day 21. The concentration of oestradiol-17β was high at the time of insemination and declined significantly (P < 0.01) by day 2 after insemination. It was maintained around the basal level till day 18 with minor peaks in between this period. It again rose significantly (P < 0.01) at subsequent oestrus. The mean level of LH was highest at the time of insemination, and declined significantly (P < 0.01) by day 1 post insemination. It did not vary appreciably till the animal returned to oestrus. The oestrous value of LH and progesterone were negatively correlated (r = −0.77). The androgen level was observed to be high at insemination in 3 out of 5 animals, but the overall pattern of this steroid was inconsistent during the period studied. A high concentration of androgen was recorded in all the animals from day 2–5 before the onset of oestrus.

DIE AUSSCHEIDUNG VON TESTOSTERON UND EPITESTOSTERON BEI FRAUEN AM ENDE DER SCHWANGERSCHAFT

1969 ◽  
Vol 60 (4) ◽  
pp. 579-585
Author(s):  
K. Schollberg ◽  
E. Seiler ◽  
J. Holtorff
Keyword(s):  
Urinary Excretion ◽  
Late Pregnancy ◽  
Mean Values ◽  
Pregnant Females ◽  
Female Foetus ◽  
The Mean ◽  
The Difference ◽  
Normal Women ◽  
In Pregnancy

ABSTRACT The urinary excretion of testosterone and epitestosterone by women in late pregnancy has been studied. The mean values of 22 normal women in pregnancy mens X are 12.9 ± 9.2 μg/24 h in the case of testosterone and 16.1 ± 16.2 μg/24 h in the case of epitestosterone. Both values do not differ significantly from those of non-pregnant females. The excretion values of mothers bearing a male foetus (17.3 ± 8.9 μg/24 h) are higher than those of mothers with a female foetus (6.4 ± 4.8 μg/24 h). The difference is statistically significant with P = 0.01.

URINARY EXCRETION OF LUTEINIZING HORMONE IN BOYS AND ADULT MEN

1970 ◽  
Vol 46 (2) ◽  
pp. 229-236 ◽  
Author(s):  
N. SCIARRA ◽  
U. LEONE
Keyword(s):  
Luteinizing Hormone ◽  
Urinary Excretion ◽  
Haemagglutination Inhibition ◽  
Adult Child ◽  
Mean Value ◽  
Sharp Rise ◽  
Adult Men ◽  
Immunological Method ◽  
The Mean

SUMMARY The daily urinary excretion of luteinizing hormone (LH) was determined in 15 boys, aged 5–11 yr., and in 15 adult men, aged 18–65 yr., by an immunological method using the haemagglutination inhibition system. The hormone was detected in every subject investigated. The mean value for urinary LH excretion in boys was equivalent to 3·4 i.u./24 hr. (range 1·3–6·5) and was 29·3 i.u./24 hr. in adults (range 15·4–44·6). The mean adult: child ratio was 8·6. There was a significant increase in LH output with age in both the boys and the men; the rate of this increase was the same in both groups. However, there was a sharp rise in hormone output at about the onset of puberty.

Sign in / Sign up

Export Citation Format

Share Document